Feb 29, 2024
Nov 23, 2023
Aug 25, 2023
June 15, 2023
Week 18, 2023
May 12, 2023
February 28, 2023
February 9, 2023
November 24, 2022
August 26, 2022
May 19, 2022
May 11, 2022
Week 17, 2022
February 25, 2022
November 12, 2021
July 16, 2021
June 17, 2021
Week 17, 2021
May 7, 2021
February 10, 2021
November 12, 2020
July 17, 2020
May 26, 2020
May 15, 2020
February 14, 2020
November 15, 2019
August 19, 2019 at 9.00am
August 15, 2019
RLS Global har sedan tidigare bjudit in investerare, analytiker och media att deltaga vid RLS’s bolagspresentation den 27 maj. Då flera intresserade inte har möjlighet att på plats närvara, väljer RLS att istället genomföra bolagspresentationen digitalt den 28 maj kl 10.30. Anmälan för att få tillgång till webblänk görs genom att skicka epost till kristina.runge@rlsglobal.se
RLS Global is a Swedish MedTech company based in Gothenburg, founded in 1996. Through our advanced and unique Buffered Hypochlorite based Technology Platform we focus on developing products based on Gentle methods for Minimally Invasive Treatment.
RLS Global AB
Neongatan 5
SE 431 53 Mölndal
Sweden
Customer Services & Orders:
+46 31 780 68 20
customer@rlsglobal.com
Office
+46 31 780 68 20
customer@rlsglobal.com
I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
How does it work?
Using ChloraSolv
ChloraSolv consists of two solutions provided in a double syringe. The solutions are mixed to form a gel at the time of use. The gel is applied on the wound bed and allowed to act for 2 minutes to soften the devitalized tissue. A blunt instrument is then used to help in the mechanical removal devitalized tissue from the application site. Finish the procedure with a second application of the gel directly onto the wound area to completely clean the wound bed.
ChloraSolv – a valuable addition in the treatment of infected diabetic foot ulcers providing non-surgical debridement
We use cookies to help us deliver our services and provide personalised experiences. By using this website, you agree to our use of cookies.
